Tower Research Capital LLC (Trc) Ars Pharmaceuticals, Inc. Comm Transaction History
Tower Research Capital LLC (Trc)
- $3.39 Billion
- Q3 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Ars Pharmaceuticals, Inc. Comm stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 7,453 shares of SPRY stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,453
Previous 6,284
18.6%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions